Catalyst Wire Dossier Catalyst Wire Dossier

Fimasartan/Atorvastatin

· Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fimasartan/Atorvastatin, covering 2019-11-05 to 2019-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia [Phase 3]

See pricing